Kaiser Permanente
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Kaiser Permanente sits in the top decile of US sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count).
Kaiser Permanente: 294 sponsored US clinical trials, 21 recruiting.
Kaiser Permanente sponsors 294 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 228 completed. 28 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 6 trials.
Top-decile sponsor footprint
Kaiser Permanente ranks in the top decile of sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 238 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
294 total, page 5 of 6
Promoting Adherence to Improve Effectiveness of Cardiovascular Disease Therapies
NCT01251757
Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease
NCT01588067
Diabetes Prevention Strategies in Women With Gestational Diabetes Mellitus (GDM)
NCT01344278
Antidepressant Adherence Via AD_IVR
NCT01188135
Acupuncture and Chiropractic Care for Chronic Pain in an Integrated Health Plan
NCT01345409
Affixing Polypropylene Mesh Using Barbed Suture (Quill™ Srs) During Laparoscopic Sacrocolpopexy Randomized Controlled Trial (Quill Lsc)
NCT01551992
Prevention of Contrast Renal Injury With Different Hydration Strategies
NCT01218828
Adaptation of the Diabetes Prevention Program for Primary Care
NCT01220089
Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy
NCT01280604
The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body Composition
NCT01141972
Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
NCT01263028
Call-2-Health: Preventing Type II Diabetes
NCT01827826
Dosing Study of Massage for Neck Pain
NCT01122836
An Evaluation of Clinical Pharmacist-led Intervention on Clinical Outcomes in Patients With Ischemic Stroke
NCT01876667
'Questions About Quitting' Smoking Cessation Trial
NCT00992264
e-Care for Heart Wellness
NCT01077388
Alcohol Drinking as a Vital Sign
NCT01135654
Investigator-Sponsored Protocol - Continued Use of Ibalizumab
NCT01056393
Weight Management for Improved Pregnancy Outcomes
NCT00950235
Young Adult and Teen Sleep Study
NCT00949689
CHOICES: Understanding Clinical Trials as a Treatment Option
NCT00983866
Organized Self-Management Support Services for Chronic Depression
NCT01139060
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up Supplement
NCT01052922
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)
NCT00790517
Patient Portal to Support Treatment Adherence
NCT00923624
A Randomized Trial Comparing Two Doses of Portion-Controlled Foods Within a Primary Care Weight Loss Program
NCT00907660
Feasibility of Depression Care Management by E-mail
NCT00755235
Evaluation of the Online Chronic Disease Self-Management Project at Group Health
NCT01122823
Effectiveness of The Step Up Wellness Program for People With Depression
NCT00644995
Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica
NCT00668434
Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial
NCT00779493
Urinary Incontinence: Reproductive/Hormonal Risk Factors
NCT00836979
Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)
NCT00517686
Home Blood Pressure Monitoring Project
NCT01162759
Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up
NCT00697047
A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
NCT01387893
Study Testing Patient Decision Tools Related to the Risks and Benefits of Weight Loss Surgery
NCT00666952
Focusing Implementation to Bring Effective Reminders (FIBER)
NCT00656838
Pacific Kids DASH for Health
NCT00905411
Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
NCT01580618
Self-Managing HIV and Chronic Disease
NCT01032824
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
NCT00529243
Therapeutic Massage for Generalized Anxiety Disorder
NCT00515242
Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma
NCT00414817
Effect of Yoga Vs. Stretching on Chronic Back Pain
NCT00447668
Linking Self-Management and Primary Care for Diabetes 2
NCT00987285
Study of Adolescence and Depression
NCT00523081
Effect of Massage on Chronic Low Back Pain
NCT00371384
Acetaminophen Before Vaccines for Infants Study (AVIS)
NCT00325819
Improving Blood Pressure in Colorado
NCT00520988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 21 |
| Phase 3 | 20 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Kaiser Permanente pipeline
21 recruiting of 294 indexed (7% open); 228 completed (78%).
Phase mix: 28 late (III/IV) vs 27 early (I/II) (balanced across stages).
Top condition: Depression (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kaiser Permanente: open-pipeline peers nationwide
Peers matched on 294 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Kaiser Permanente sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 294 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Mannkind Corporation · 7% recruiting · 42 trials
- Minneapolis Veterans Affairs Medical Center · 7% recruiting · 28 trials
Related
What to do with this Kaiser Permanente page
294 registered trials is a research-attention snapshot, not an endorsement of Kaiser Permanente or any single study.
- 21 of Kaiser Permanente's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Kaiser Permanente studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kaiser Permanente pipeline card: 294 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.